fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2007-07-23 IIa Result Sygnis Pharma (Germany)   AX200 protein (filgrastim - G-CSF) acute stroke Germany See details
2007-07-23 IIb Launch BioXell (Italy)   elocalcitol overactive bladder Italy, UK, Netherlands See details
2007-07-19 I Launch Affiris (Austria)   Affitope AD01 (Alzheimer's vaccine) Alzheimer disease Austria See details
2007-07-17 I Launch Acambis (UK)   ACAM-FLU-A (universal influenza vaccine) influenza USA See details
2007-07-16 II Launch Intercell (Austria) Biological E.Ltd (india)   IC51 - japanese encephalitis vaccine japanese encephalitis India See details
2007-07-11 I Launch Micromet (Germany/USA) Tracon Pharmaceuticals (USA)   D93/TRC093 (humanized monoclonal antibody that binds to cleaved collagen to inhibit angiogenesis and tumor growth)     See details
2007-07-03 II Result Cytos Biotechnology (Switzerland)   CYT003-QbG10 atopic dermatitis   See details
2007-06-29 III Launch Nicox (France)   naproxcinod Hip arthrosis USA See details
2007-06-28 IIa Result Speedel (Switzerland)   SPP635 (renin inhibitor) hypertension   See details
2007-06-26 II Launch Biogen Idec (USA) UCB (Belgium) CDP323 (integrin alpha-4 antagonist) multiple sclerosis Europe and USA See details
2007-06-25 II Result deCODE Genetics (Iceland)   antiplatelet agent DG041 (an EP3 prostaglandin E2 receptor antagonist)     See details
2007-06-25 I Launch Innate Pharma (France) Novo Nordisk (Denmark) IPH 2101 (human monoclonal antibody which blocks the KIR inhibitory receptors in NK cells) multiple myeloma USA See details
2007-06-21 II Launch LifeCycle Pharma (Denmark)   LCP-Tacro (a tacrolimus formulation) prevention of kidney transplant rejection USA, Canada See details
2007-06-21 II Result Antisense Pharma (Germany)   AP 12009 (antisense nucleotide inhibitor of TGF-beta 2) recurrent glioma 29-centres international study See details
2007-06-19 I Launch Intercell (Austria)   The IC31® adjuvant in a novel formulation of a seasonal influenza vaccine     See details
[<<]      «      43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53      »      [57]